New Ebola screening to start at 5 airports in US

Five U.S. Airports Are Enacting New Screening Measures to Protect Against Ebola – The Centers for Disease Control and Prevention (CDC), USA and the Department of Homeland Security (DHS), USA announced that the following five U.S. airports will soon begin enhanced Ebola screening for all travelers coming from Ebola-affected countries

Tighter Ebola Screening for Travelers From West Africa – Obama

U.S. working on new screenings for Ebola but no travel ban — U.S. will augment Ebola screenings for airline passengers in U.S. and Africa – U.S. President Barack Obama met with members of his national security team and senior staff to receive an update on the Ebola outbreak in West Africa and the administration’s response efforts at the White House in Washington October 6, 2014.

US Travel Warning to avoid travel to West African nations

As West Africa Ebola outbreak worsens, CDC issues Level 3 Travel Warning — CDC surge scaling up response in Guinea, Sierra Leone, and Liberia – The Centers for Disease Control and Prevention (CDC) issued a warning to avoid nonessential travel to the West African nations of Guinea, Liberia, and Sierra Leone. This Level 3 travel warning is a reflection of the worsening Ebola outbreak in this region.

New blood test predicts breast cancer risk

New test predicts the risk of non-hereditary breast cancer — A simple blood test is currently in development that could help predict the likelihood of a woman developing breast cancer – A simple blood test is currently in development that could help predict the likelihood of a woman developing breast cancer, even in the absence of a high-risk BRCA1 gene mutation. This new research is published in the Genome Medicine.

Breathalyzer test detects lung cancer 90% accuracy

Breathalyzer Test May Detect Deadliest Cancer — Researchers from TAU and partner institutions develop groundbreaking device that spots lung cancer – to stop it in its tracks – A new device developed by a team of Israeli, American, and British cancer researchers may turn the tide by both accurately detecting lung cancer and identifying its stage of progression.

Preventing disparities in colon cancer screening

How to prevent disparities in colon cancer screening – People living in poverty are less likely to be screened regularly for colorectal cancer — and more likely to develop the disease and die from it. How to end these disparities — and raise screening rates, lower disease rates, and prevent deaths?

Mammography screening for breast cancer needs individualized approach

The mammography dilemma — Complex benefits and harms of mammography require individualized approach – A comprehensive review of 50 year’s worth of international studies assessing the benefits and harms of mammography screening suggests that the benefits of the screening are often overestimated, while harms are underestimated.

Screen high risk populations for lung cancer – final lung cancer screening recommendations

Final recommendations on lung cancer screening — Final word: Task Force says screen high-risk populations for lung cancer – High-risk adults between the ages of 55 and 80 should receive annual lung cancer screening with low-dose computed tomography, according to final recommendations from the U.S. Preventive Services Task Force being published in Annals of Internal Medicine.

New therapeutic targets for treating Parkinson’s disease

Gene-silencing study finds new targets for Parkinson’s disease — NIH study sheds light on treatment of related disorders – Scientists at the National Institutes of Health have used RNA interference (RNAi) technology to reveal dozens of genes which may represent new therapeutic targets for treating Parkinson’s disease. The findings also may be relevant to several diseases caused by damage to mitochondria, the biological power plants found in cells throughout the body.

Biomarker CA-125 shows promise as screening tool for early detection of ovarian cancer

CA-125 change over time shows promise as screening tool for early detection of ovarian cancer — Blood test used to find recurrence uncovers invasive, high-grade disease at curable stage – CA-125, the protein recognized for predicting ovarian cancer recurrence, now shows promise as a screening tool for early-stage disease of ovarian cancer. The simple blood test could offer a much-needed screening tool to detect ovarian cancer in its early stages – even in the most aggressive forms.

Personalized Strategies to Reduce Cancer Overtreatment

Major Changes Urged for Cancer Screening and Treatment — Scientific Panel Recommends New Personalized Strategies to Reduce Cancer Overtreatment – To address the growing problem of people being overdiagnosed and overtreated for cancer, a group of scientists convened by the National Cancer Institute and chaired by a UC San Francisco breast cancer expert is proposing a major update of the way the nation approaches diseases now classified as “cancer.”

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | SpiritIndia